Not only are there more dollars being place in value-based contracts, but the healthcare community is starting to see the benefits of these programs, explained Scott Hewitt, vice president, payment strategy and innovation, UnitedHealthcare.
Not only are there more dollars being place in value-based contracts, but the healthcare community is starting to see the benefits of these programs, explained Scott Hewitt, vice president, payment strategy and innovation, UnitedHealthcare.
Transcript
What has been physician interest in participating in value-based contracts? Are you seeing some skepticism disappear?
One of the things that we’ve been doing, as I’m sure most payers are, is tracking what is our evolution in terms of moving to value-based contracting. In 2012, when United Healthcare first started tracking this information, we had roughly $12 billion in spend tied to value-based contracts. Now 5 years later, 6 years later, we have almost $70 billion tied to value-based contracts and not only do we have more dollars tied to value-based contracts, we’re seeing the evolution move form a preponderance of performance-based contracts—so metrics-specific programs—to more programs that are more focused on bundled payments and population health.
So, I think that the provider community, the entire healthcare landscape, is changing to the point where we are seeing the benefits of these programs. Certainly, with the actions that CMS is taking, actions that UnitedHealthcare is taking, actions that employers and states are asking of UnitedHealthcare to undertake. This is the direction that people want to move, and it’s the direction that people should be moving. I mean there’s no other industry where we simply increase reimbursement to somebody—you and I as employees don’t just automatically get a rate increase or our salaries don’t go up on an annual if we’re not performing at a higher level, right, as an example.
We need to bring in more components where we look at the cost and quality of healthcare and how is it being delivery, how is it being received by the members? Is it making a difference? So, I understand the question in terms of providers saying, “I’ve got all these different programs, all these different metrics that I’m being asked to look at. Is it actually resulting in a benefit for the consumer?” And I would think—I know—that the data at UnitedHealthcare shows that it is.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More